The article reviews the impact of respiratory syncytial virus (RSV) on global health, emphasizing its significant burden on infants, children, and the elderly. It discusses current and emerging prevention strategies, including the development and implementation of vaccines and monoclonal antibodies. ... The review highlights advancements in RSV research, the challenges of creating effective vaccines for different age groups, and the importance of global collaboration to reduce RSV-associated morbidity and mortality. It also calls for increased investment in research and public health measures to enhance prevention and treatment options. more

3 March 2022 The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf ... format (via the ‘Download’ button) and via an online platform, and is updated regularly as new evidence emerges. more

Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid ... ity and avoidable deaths. The consequences of poorly controlled asthma, including physical, mental, social, and economic impacts, are magnified in the poor on account of poor access to asthma services and sub-optimal quality of those services. With these guidelines, Kenya's Ministry of Health aims to work towards embedding asthma care in Universal Health Care (UHC) to ensure that quality asthma services are available in primary care settings with referral networks strengthened for those who may require secondary and tertiary care. These national asthma guidelines will also ensure that treatment for asthma is standardized in both the public and the non-state health care sector. more

Вариативные рекомендации 24 сентября 2021 г. Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения, касающиеся нов ... ых средств для лечения COVID-19, в том числе гидроксихлорохина и комбинации лопинавира и ритонавира . Размещение, распространение и обновление данных рекомендаций происходит в приложении MAGICapp, а их формат и структура обеспечивают для пользователей удобство работы и поиска. Реализована функция постоянного обновления информации, относящейся к действующим положениям, которая позволяет знакомиться с новыми данными наряду с актуальными рекомендациями. В разделе 4 описаны основные методологические аспекты процедуры составления вариативных рекомендаций. more